Company: SCAG
Filing Date: 2025-01-06
Form Type: 424B3
Source: 0001213900-25-001215
Chunk: 442

Company: Scage Future
Filing Date: 2025-01-06
Form: 424B3
Chunk 442
---
 statements. The unaudited pro forma combined financial information has been prepared assuming two alternative levels of redemption into cash of Finnovate’s ordinary shares: • Scenario 1—Assuming no further redemption of Finnovate’s ordinary shares for cash since the last redemption of 1,383,214 shares in November 2024: This presentation assumes that no public shareholders of Finnovate exercise redemption rights with respect to their ordinary shares upon consummation of the Transactions; and • Scenario 2—Assuming redemptions of 865,292 ordinary shares of Finnovate for cash: This presentation assumes that public shareholders of Finnovate will exercise their redemption rights with respect to a maximum of 865,292 ordinary shares. The maximum redemption scenario is determined based on the Finnovate shareholders’ approval of amending the charter to remove the requirement that Finnovate has net tangible assets of $5,000,001 upon the close of the Business Combination (“Contractual Maximum Redemption”). Consequently, under the Contractual Maximum Redemption scenario, there are no share of Finnovate Public Shares remaining, upon the Closing. Included in the shares outstanding and weighted average shares outstanding as presented in the pro forma combined financial statements are approximately 67,482,417 Ordinary Shares of PubCo to be issued to the Sellers in the form of PubCo ADSs, such amount calculated using Scage’s aggregate ordinary shares issued and outstanding on an as -convertedbasis as of June30, 2024 (but excluding ordinary shares to be issued upon the conversion of convertible debts) times Exchange Ratio. Exchange Ratio (approximately 0.4841 as calculated below) represents the quotient obtained by dividing (i) the Company Merger Shares (approximately 67,848,091shares as calculated below) as of the First Merger Effective Time divided by (ii) the aggregate number of, without duplication, Company Ordinary Shares that are (i) issued and outstanding, and (ii) issuable directly or indirectly upon, or subject to, the conversion, exercise or settlement of any Company Preferred Shares and Company Convertible Securities (including Scage’s 104,766,463 ordinary shares issued and outstanding as of June30, 2024, Scage’s 3,442,342 ordinary shares issuable upon the receipt of investment in November 2024, Scage’s 31,191,586 convertible redeemable preferred shares issued and outstanding as of June30, 2024, and 755,383 ordinary shares issuable upon the conversion of an